Synlett 2024; 35(19): 2155-2173
DOI: 10.1055/a-2222-1667
account
Isotopic Labeling

Method Development and Syntheses Examples of Isotopically Labeled Compounds to Foster Operational Excellence in Pharma Industry

Anna Sib
,
Volker Derdau


The manuscript is dedicated to Prof. Laschat at the occasion of her 60th birthday – thanks Sabine.

Abstract

The different topics and synthetic approaches in an isotope chemistry laboratory of a pharma company are described. Besides the challenges in the synthesis of long-lived isotopes such as 3H or 14C, short-lived isotopes such as 68Ga and stable isotopes such as 15N, 13C or 2H approaches for the isotopic labeling are also demonstrated. Furthermore, method development with emphasis on collaborations with academic groups to tackle the future challenges are discussed.

1 Introduction

2 Isotopic Labeling with Hydrogen Isotopes Deuterium (2H, D) and Tritium (3H, T)

2.1 Deuterium Labeling for MS Standards

2.1.1 Labeled Nitrosamines – The Hunt to Quantify Hazardous Impurities

2.1.2 Deuterated Drugs, an Approach To Improve Existing Drugs or To Find Opportunities in Drug Discovery

2.2 Tritium-Labeling Methods – The Fast Approach to Radioactively Labeled Compounds

2.2.1 Hydrogen Isotope Exchange by Iridium Catalysis

2.2.2 Ruthenium-Catalyzed HIE

2.2.3 Nanoparticles as Catalysts in HIE

2.2.4 Photoredox-Catalyzed HIE

2.2.5 HIE via Classical Radical Mechanism

2.2.6 Beyond HIE – Halogen–Tritium Exchange

3 Challenges in 14C-Synthesis Projects

4 Short-Lived Isotopes – The Need for Speed

5 Beyond Isotope Science – Late-Stage Functionalization

5.1 Examples of Late-Stage Functionalization for Peptides

5.2 Examples of Catalyst-Controlled Late-Stage Functionalization

6 Conclusion



Publication History

Received: 31 October 2023

Accepted after revision: 04 December 2023

Accepted Manuscript online:
04 December 2023

Article published online:
17 January 2024

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes


    • For reviews on the synthesis of isotopically labelled compounds, see:
    • 1a Atzrodt J, Derdau V, Fey T, Zimmermann J. Angew. Chem. Int. Ed. 2007; 46: 7744 ; Angew. Chem. 2007, 119, 7890
    • 1b Atzrodt J, Derdau V, Kerr WJ, Reid M. Angew. Chem. Int. Ed. 2018; 57: 3022 ; Angew. Chem. Int. Ed. 2018, 57, 3074
    • 1c Kopf S, Bourriquen F, Li W, Neumann H, Junge K, Beller M. Chem. Rev. 2022; 122: 6634
    • 1d Prakash G, Paul N, Oliver GA, Werz DB, Maiti D. Chem. Soc. Rev. 2022; 51: 3123
    • 1e Kerr WJ, Knox GJ, Paterson LC. J. Labelled Compd. Radiopharm. 2020; 63: 281

      For selected reviews, see:
    • 2a Elmore CS, Bragg RA. Bioorg. Med. Chem. Lett. 2015; 25: 167
    • 2b Lockley WJ. S, McEwen A, Cooke R. J. Labelled Compd. Radiopharm. 2012; 55: 235
    • 2c Mutilib AE. Chem. Res. Toxicol. 2008; 21: 1672
    • 2d Atzrodt J, Derdau V, Kerr WJ, Reid M. Angew. Chem. Int. Ed. 2018; 57: 1758 ; Angew. Chem. 2018, 130, 1774
    • 2e Derdau V, Elmore CS, Hartung T, McKillican B, Mejuch T, Rosenbaum C, Wiebe C. Angew. Chem.Int. Ed. 2023; e202306019
  • 3 Stokvis E, Rosing H, Beijnen JH. Rapid Commun. Mass Spectrom. 2005; 19: 401
  • 4 Neubert L, Michalik D, Bähn S, Imm S, Neumann H, Atzrodt J, Derdau V, Holla W, Beller M. J. Am. Chem. Soc. 2012; 134: 12239

    • For reviews, see:
    • 5a Dobereiner GE, Crabtree RH. Chem. Rev. 2010; 110: 681
    • 5b Nixon TD, Whittlesey MK, Williams JM. J. Dalton Trans. 2009; 753
    • 5c Lamb GW, Williams JM. J. Chim. Oggi 2008; 26: 17
    • 5d Hamid MH. S. A, Slatford PA, Williams JM. J. Adv. Synth. Catal. 2007; 349: 1555
  • 6 Derdau V. Tetrahedron Lett. 2004; 45: 8889
  • 7 Yamada T, Park K, Yasukawa N, Morita K, Monguchi Y, Sawama Y, Sajiki H. Adv. Synth. Catal. 2016; 358: 3277
    • 8a Derdau V, Sandvoss M. J. Labelled Compd. Radiopharm. 2023; 66: 41
    • 8b Shaik KM, Sarmah B, Wadekar GS, Kumar P. Crit. Rev. Anal. Chem. 2022; 52: 53
  • 9 Di Martino RM. C, Maxwell BD, Pirali T. Nat. Rev. Drug Discovery 2023; 22: 562

    • For selected reviews, see:
    • 10a Heys JR. J. Labelled Compd. Radiopharm. 2007; 50: 770
    • 10b Nilsson GN, Kerr WJ. J. Labelled Compd. Radiopharm. 2010; 53: 662
    • 10c Salter R. J. Labelled Compd. Radiopharm. 2010; 53: 645
    • 10d Allen PH, Hickey MJ, Kingston LP, Wilkinson DJ. J. Labelled Compd. Radiopharm. 2010; 53: 731
    • 10e Atzrodt J, Derdau V. J. Labelled Compd. Radiopharm. 2010; 53: 674
  • 11 Kerr WJ, Lindsay DM, Reid M, Atzrodt J, Derdau V, Rojahn P, Weck R. Chem. Commun. 2016; 52: 6669
  • 12 Crabtree RH. Acc. Chem. Res. 1979; 12: 331
    • 13a Brown JA, Irvine S, Kennedy AR, Kerr WJ, Andersson S, Nilsson GN. Chem. Commun. 2008; 1115
    • 13b Cochrane AR, Idziak C, Kerr WJ, Mondal B, Paterson LC, Tuttle T, Andersson S, Nilsson GN. Org. Biomol. Chem. 2014; 12: 3598
    • 13c Brown JA, Cochrane AR, Irvine S, Kerr WJ, Mondal B, Parkinson JA, Paterson LC, Reid M, Tuttle T, Andersson S, Nilsson GN. Adv. Synth. Catal. 2014; 356: 3551
    • 13d Kennedy AR, Kerr WJ, Moir R, Reid M. Org. Biomol. Chem. 2014; 12: 7927
    • 13e Kerr WJ, Mudd RJ, Paterson LC, Brown JA. Chem. Eur. J. 2014; 20: 14604
    • 13f Atzrodt J, Derdau V, Kerr WJ, Reid M, Rojahn P, Weck R. Tetrahedron 2015; 71: 1924
    • 13g Kerr WJ, Mudd RJ, Owens PK, Reid M, Brown JA, Campos S. J. Labelled Compd. Radiopharm. 2016; 59: 601
    • 13h Kerr WJ, Lindsay DM, Owens PK, Reid M, Tuttle T, Campos S. ACS Catal. 2017; 7: 7182
  • 14 Parmentier M, Hartung T, Pfaltz A, Muri D. Chem. Eur. J. 2014; 20: 11496
    • 15a Burhop A, Weck R, Atzrodt J, Derdau V. Eur. J. Org. Chem. 2017; 11: 1418
    • 15b Burhop A, Prohaska R, Weck R, Atzrodt J, Derdau V. J. Labelled Compd. Radiopharm. 2017; 60: 343
    • 16a Han Z, Wang Z, Zhang X, Ding K. Angew. Chem. Int. Ed. 2009; 48: 5345
    • 16b Please note that to our knowledge this catalyst has never been used in HIE reactions before.
  • 17 Valero M, Mishra A, Blass J, Weck R, Derdau V. ChemistryOpen 2019; 8: 1183
  • 18 Valero M, Weck R, Güssregen S, Atzrodt J, Derdau V. Angew. Chem. Int. Ed. 2018; 57: 8159
  • 19 Kerr WJ, Mudd RJ, Reid M, Atzrodt J, Derdau V. ACS Catal. 2018; 8: 10895
  • 20 Morawietz P, Weck R, Atzrodt J, Güssregen S, Derdau V. Green Chem. 2022; 24: 4824
  • 21 Stork CM, Weck R, Valero M, Kramp H, Güssregen S, Waldvogel SR, Sib A, Derdau V. Angew. Chem. Int. Ed. 2023; 62: e202301512
  • 22 Kerr WJ, Knox GJ, Reid M, Tuttle T, Bergare J, Bragg RA. ACS Catal. 2020; 10: 11120
  • 23 Jess K, Derdau V, Weck R, Atzrodt J, Freytag M, Jones PG, Tamm M. Adv. Synth. Catal. 2017; 359: 629
  • 24 Valero M, Becker D, Jess K, Weck R, Bannenberg T, Atzrodt J, Derdau V, Tamm M. Chem. Eur. J. 2019; 25: 6517
  • 25 Ma S, Villa G, Thuy-Boun PS, Homs A, Yu J.-Q. Angew. Chem. Int. Ed. 2014; 53: 734 ; Angew. Chem. 2014, 126, 753
  • 26 Yang H, Dormer PG, Rivera NR, Hoover AJ. Angew. Chem. Int. Ed. 2018; 57: 1883
  • 27 Burhop A, Weck R, Atzrodt J, Derdau V. Eur. J. Org. Chem. 2017; 1418
  • 28 Burhop A, Prohaska R, Weck R, Atzrodt J, Derdau V. J. Labelled Compd. Radiopharm. 2017; 60: 343
  • 29 Müller V, Weck R, Derdau V, Ackermann L. ChemCatChem 2020; 12: 100
  • 30 Valero M, Bouzouita D, Palazzolo A, Atzrodt J, Dugave C, Tricard S, Feuillastre S, Pieters G, Chaudret B, Derdau V. Angew. Chem. Int. Ed. 2020; 59: 3517
  • 31 Daniel-Bertrand M, Garcia-Argote S, Palazzolo A, Mustieles Marin I, Fazzini P.-F, Tricard S, Chaudret B, Derdau V, Feuillastre S, Pieters G. Angew. Chem. Int. Ed. 2020; 59: 21114
  • 32 For a review of photoredox-catalyzed CH functionalization, see: Holmberg-Douglas N, Nicewicz DA. Chem. Rev. 2022; 122: 1925
  • 33 Loh YY, Nagao K, Hoover AJ, Hesk D, Rivera NR, Coletti SL, Davies IW, MacMillan DW. C. Science 2017; 358: 1182
  • 34 Legros F, Fernandez-Rodriguez P, Mishra A, Weck R, Bauer A, Sandvoss M, Ruf S, Méndez M, Mora-Radó H, Rackelmann N, Pöverlein C, Derdau V. Chem. Eur. J. 2020; 26: 12738
  • 35 Murugesan K, Donabauer K, Narobe R, Derdau V, Bauer A, König B. ACS Catal. 2022; 12: 3974
  • 36 Yang H, Huang Z, Lehnherr D, Lam Y, Ren S, Strotman NA. J. Am. Chem. Soc. 2022; 144: 5010
  • 37 Kramp H, Weck R, Sandvoss M, Sib A, Mencia G, Fazzini P.-F, Chaudret B, Derdau V. Angew. Chem Int. Ed. 2023; 62: e202308983
  • 38 Wang L, Xia Y, Derdau V, Studer A. Angew. Chem Int. Ed. 2021; 60: 18645
  • 39 Jones S, Weck R, Burhop A, Atzrodt J, Derdau V. J. Labelled Compd. Radiopharm. 2018; 61:  895
  • 40 Duran GE, Derdau V, Weitz D, Philippe N, Blankenstein J, Atzrodt J, Sémiond D, Gianolio DA, Macé S, Sikic BI. Cancer Chemother. Pharmacol. 2018; 81: 1095
  • 41 Krauser JA. J. Labelled Compd. Radiopharm. 2013; 56: 441

    • For reviews about 14C synthesis, see:
    • 42a Voges R, Heyes JR, Moenius T. Preparation of Compounds Labeled with Tritium and Carbon-14 . John Wiley & Sons; Hoboken: 2009
    • 42b Derdau V. J. Labelled Compd. Radiopharm. 2018; 61: 1012
    • 42c Bragg RA, Sardana M, Artelsmair M, Elmore CS. J. Labelled Compd. Radiopharm. 2018; 61: 934
    • 42d Nielsen DU, Neumann KT, Lindhardt AT, Skrydstrup T. J. Labelled Compd. Radiopharm. 2018; 61: 949
    • 42e Gregson TJ, Herbert JM, Row EC. J. Labelled Compd. Radiopharm. 2011; 54: 1
  • 43 Derdau V, Fey T, Atzrodt J. Tetrahedron 2010; 66: 1472
  • 44 Derdau V, Oekonomopulos R, Schubert G. J. Org. Chem. 2003; 68: 5168

    • For reviews on carbon isotope exchange, see:
    • 45a Labiche A, Malandain A, Molins M, Taran F, Audisio D. Angew. Chem Int. Ed. 2023; 62: e202303535
    • 45b Hinsinger K, Pieters G. Angew. Chem Int. Ed. 2019; 58: 9678
  • 46 Bsharat O, Doyle MG. J, Munch M, Mair BA, Cooze CJ. C, Derdau V, Bauer A, Kong D, Rotstein BH, Lundgren RJ. Nat. Chem. 2022; 14: 1367
  • 47 Babin V, Taran F, Audisio D. JACS Au 2022; 2: 1234
  • 48 Bertrand R, Hamp I, Brönstrup M, Weck R, Lukacevic M, Polyak A, Ross TL, Gotthardt M, Plettenburg O, Derdau V. J. Labelled Compd. Radiopharm. 2016; 59: 604
  • 49 Mishra A, Castañeda TR, Bader E, Elshorst B, Cummings S, Scherer P, Bangari DS, Loewe C, Schreuder H, Pöverlein C, Helms M, Jones S, Zech G, Licher T, Wagner M, Schudok M, de Hoop M, Plowright AT, Atzrodt J, Kannt A, Laitinen I, Derdau V. Adv. Sci. 2020; 7: 2002997
  • 50 Bertrand R, Wagner M, Derdau V, Plettenburg O. Bioconjugate Chem. 2016; 27: 2281

    • For reviews on late-stage functionalization, see:
    • 51a Cernak T, Dykstra KD, Tyagarajan S, Vachal P, Krska SW. Chem. Soc. Rev. 2016; 45: 546
    • 51b Gutekunst WR, Baran PS. Chem. Soc. Rev. 2011; 40: 1976
    • 51c Abrams DJ, Provencher PA, Sorensen EJ. Chem. Soc. Rev. 2018; 47: 8925
  • 52 Brandhofer T, Stinglhammer M, Derdau V, Mendez M, Pöverlein C, García Mancheño O. Chem. Commun. 2021; 57: 6756
  • 53 Korvorapun K, Boni Y, Maier T, Bauer A, Licher T, Macor J, Derdau V, Davies H. ACS Catal. 2023; 13: 2359
  • 54 Hesk D, Jones JR, Lockley WJ. S. Label. Compd. Radiopharm. 1990; 28: 1427